Objective: The study was conducted to see the maternal and neonatal outcomes of the women with placenta praevia. Methods: All women with the diagnosis of placenta praevia admitted in the hospital were included in the study. The maternal and fetal outcomes were recorded from January 2012 to August 2017, over a period of 5 years. Results: A total of 63 patients were included in the study, after radiological confirmation. The period of gestation for the first presentation was predominantly in 28 weeks of gestation, for central placenta praevia. The mean blood loss intraoperative was 3000 ml, ranging to as much as 5500 ml in central placenta praevia and more so in posterior than anterior placenta. The need of additional procedure like uterine artery ligation was needed in 26 (41.2%), internal iliac artery ligation 8 (12.6%), B lynch in 12 (19.04%) and peripartum hysterectomy was performed in 3 (4.7%). The mean requirement of blood transfusion was 500ml of packed cell. The need of ICU care was in 5 (7.9%) and serious morbidity was seen in 3 (4.7%). Maternal mortality was not seen in any case. Fetal outcomes were studied by recording the fetal weight, Apgar and need of NICU care which was for 23 (36.5%). Conclusion: The need for early diagnosis and multispecialty approach to a patient is greatly associated with reducing the blood loss, lesser need of additional procedure and lower maternal and fetal mortality and morbidity.Keywords: Placenta praevia, accreta, antepartum hemorrhage, maternal complication.Placenta praevia means the placenta located in the lower uterine segment which is less than 2.5 cms from the cervical os 1 . This condition is complicating about 0.3 to 0.8% of all pregnancy 2-5 . The risk factors for developing placenta praevia are previously scarred uterus, grand multiparty, maternal age of more than 35 years, recurrent abortion and intrauterine curettage 6-9 .Maternal morbidity in the form of abnormal placentation, increased risk of section and additional procedure, need for blood transfusion and ICU care and fetal morbidity in the form of preterm, low birth weight, low Apgar and need for NICU care makes it a must for care in a higher center and with available advanced resources [10][11][12][13] . The most frequent management in the form of section which is on the rise in today's era more so increases the risk of placenta praevia in the next RESEARCH ARTICLE
To study the prevalence of postmenopausal women in the urban population, its clinical presentation, histopathology incidence of malignancy. Method and material: A prospective study performed in ESIC medical college, Bangalore, over 50 women. When women presented to the outpatient with complain of postmenopausal bleed there was enrolled in the study. Patient's demographic data were collected, the pap and endometrial HPE were studied. Results:The average age of menopause was 50 years. The histopathological analysis showed proliferative endometrium (16%), secretory endometrium (10%), atrophic endometrium (14%), simple hyperplasia (10%), complex hyperplasia with atypia (8%), endometrial polyp (4%) and cervical polyp in (4%). Squamous cell cervical carcinoma (10%) endocervicitis (14%) of the population and endometrial malignancy in (4%) no opinion were given in (6%). Conclusion: Postmenopausal bleeding is a sinister complaint among the elderly women. It needs a complete history, clinical examination and investigations to detect the cases of malignancy at a earlier date. High-risk women like nulligravida, obesity, diabetes, has to be considered as special case and extensively investigated to rule out malignancy.
Mrs S was detected to have fetal cardiac rhabdomyometa at 30 weeks of gestation, as the fetal echo showed multiple nonobstructive cardiac rhabdomyometa with normally connected heart and premature atrial contractions. Magnetic resonance imaging (MRI) showed no obvious cranial tubers. As the condition was isolated, patient was conservatively followed-up. Patient had an uneventful vaginal delivery. Post-delivery, fetal echocardiography showed multiple masses on the left and right side of the cardia on the tricuspid valve and was opined conservative management in view of high risk, had limited benefit for surgical intervention and as the condition would likely to improve over time. baby was stable at discharge and was put on tablet propranolol 10 mg ¼ thrice daily for selflimiting arrhythmias. How to cite this article Jyothi GS, Shivananjaiah C, Manjula NV, Swarup A. An Interesting Case of Fetal Cardiac Rhabdomyometa in Pregnancy. Int J Infertil Fetal Med 2015;6(2):92-95.
Background: Ectopic pregnancy is an obstetric emergency which if not diagnosed in time can cost the life of the patient. This emphasizes the importance of diagnosing this perilous condition and hence this study was undertaken to study symptoms with which the patients with ectopic pregnancy present. Methods: Retrospective study of 5 years was done in the department of Obstetrics and Gynecology, M. S. Ramaiah medical college and teaching hospital, Bangalore, India between January 2011 to January 2016. Detailed analysis of patients with ectopic pregnancy inclusive of the age and clinical features were studied. Results: A total of 90 patients with ectopic pregnancy were studied. 95.5% of the patients (n=86) presented with abdominal pain, 81.1% (n=73) of the patients presented with amenorrhea, 24.4% (n=22) patients presented with bleeding per vagina, 30% (n=27) patients with nausea, vomiting and 48.8% (n=44) presented with fainting and giddiness. Conclusions: It is very essential to study the symptoms of ectopic pregnancy as this may help in early detection of ectopic pregnancy and hence can reduce the mortality in this catastrophic condition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.